Product Development Policy | Research & Development | SENJU Pharmaceutica
venience for patients). We mainly identify "corneal disease," "glaucoma," "retinal disease," and "allergic conjunctivitis" as the diseases we find important in ...
http://www.senju.co.jp/english/rd/policy/